During the early part of her career, Dr. Koel Chaudhury, Ph.D worked extensively on the development of a non-hormonal injectable male contraceptive, RISUG which is presently in Phase III clinical trials. Her present research focus is on Women’s Health which includes clinical proteomics and metabolomics based biomarker discovery in endometriosis and gestational hypertension, understanding endometrial receptivity and pathogenesis of endometriosis at a molecular level and role of oxidative stress in infertility. She has successfully established the threshold level of reactive oxygen species beyond with IVF/ICSI outcome is not favourable. Dr. Chaudhury has several projects funded by the Government of India and has a large number of international publications to her credit. She is also a peer reviewer of reputed journals. She is presently working as an Associate Professor in the School of Medical Science and Technology, Indian Institute of Technology, Kharagpur, India.